Sentences with phrase «funding life science companies»

The NRC - IRAP program has been active in funding life science companies, so this money seems likely to provide a boost to the sector.

The Ontario Emerging Technologies Fund — which has met with some criticism for the onerous disclosure required to qualify as an investor and for restrictions on investees» deployment of invested funds — showed this week that it can nevertheless fund life science companies and qualify biotech investors.

Not exact matches

Existing investors Partner Fund Management, Altitude Life Science Ventures, and Fidelity Management & Research Company participated.

• Grail, a life sciences company focused on early cancer detection that operates as a subsidiary of Illumina Inc. (Nasdaq: ILMN), raised more than $ 900 million in Series B funding.

For example, my fund, ScienceVest, focuses on science - tech and life - science companies.

• Excision BioTherapeutics, a Philadelphia - based life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment of life - threatening disease caused by neurotropic viruses, raised $ 10 million in seed funding.

My company has been able to organize funding through 2 companies inn Europe: SO Ventures (life sciences) and eSolve Capital, which through their eSolveNano division (http://esolvenano.com) offers a very well placed aggregating function for hitech sectors.

We are a family of venture funds and accelerators that invest in technology and life sciences companies.

Funded by the Government of Ontario, the fund helps innovative life sciences companies turn their discoveries into new products and services that meet patient needs.

About Investment Accelerator Fund - Life Sciences The Investment Accelerator Fund - Life Sciences (IAF - LS) helps accelerate the growth of life sciences companies in OntaLife Sciences The Investment Accelerator Fund - Life Sciences (IAF - LS) helps accelerate the growth of life sciences companies in OntaLife Sciences (IAF - LS) helps accelerate the growth of life sciences companies in Ontalife sciences companies in Ontario.

The Investment Accelerator Fund - Life Sciences (IAF - LS) helps accelerate the growth of life sciences companies in OntaLife Sciences (IAF - LS) helps accelerate the growth of life sciences companies in Ontalife sciences companies in Ontario.

The FAN Fund was established to invest professionally managed angel capital in growth - oriented companies in the technology and life science sectors in Florida.

The Roche Venture Fund invests to develop commercially successful innovative life science companies.

Represented venture capital fund in its investment and purchase of preferred stock of various life science companies in which it is lead investor.

Ohio TechAngel Funds (OTAF) is a group of for - profit angel investor funds, managed by Rev1 Ventures, that invests in highly promising, Ohio - based companies in IT, advanced materials, and life scieFunds (OTAF) is a group of for - profit angel investor funds, managed by Rev1 Ventures, that invests in highly promising, Ohio - based companies in IT, advanced materials, and life sciefunds, managed by Rev1 Ventures, that invests in highly promising, Ohio - based companies in IT, advanced materials, and life sciences.

The fund managers will look for companies concentrated in the sectors of information and communication technology, clean and energy technology, life sciences, as well as agriculture and biotech.

Led by OrbiMed Advisors, an investment management firm focused on the healthcare sector, Caduceus Private Investment funds invest primarily in US mid and late stage private life science companies and medical technologies.

He receives funding from the GRDC, ACIAR and an international life science company.

The Bloomberg administration is working with large pharmaceutical companies and venture capitalists to create a $ 100 million fund to invest in fledgling life sciences companies.

He supported himself by consulting for a startup company developing a science - crowd - funding platform, and he lived off savings he had set aside during his postdoc.

A # 14 million, five - year partnership between the BBSRC, the Engineering and Physical Science Research Council and a consortium of leading companies such as GlaxoSmithKline and Pall Life Sciences, it aims to fund innovative biotechnology - related research across several universities.

Early Stage Investors and Strategic Partners Matched with Fundraising CEOs and Scientist - Entrepreneurs The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

Toronto and Vancouver, Canada - Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once - daily therapeutic to prevent low blood glucose levels (hypoglycemia), has secured US$ 3.9 million in non-dilutive funding from The Leona M. and Harry B. Helmsley Charitable Trust.

This is one of many small blind spots in the life sciences, places where the lack of basic development, documentation, and tooling has led to company after company, research group after research group deciding to do something else with their limited funds rather than be forced into building every last part of the basic toolkit they'd need to even get started.

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

Lundbeckfonden Ventures is an evergreen venture fund with a portfolio of approx. 20 life science companies primarily in Europe and the USA.

Clients include multinational companies, state - owned enterprises and sovereign wealth funds active across a range of sectors, including shipping, pharmaceuticals, healthcare and life sciences, consumer goods, food and beverages, mining and IT.

As life science companies look to consolidate operations, acquire products or technology, divest themselves of non-strategic products or functions, or attract partners and research funding, they rely on Blakes, a leader in M&A, securities, finance and competition law.

The Warsaw office of Noerr has advised PFR Life Science, a subsidiary of the Polish Development Fund, which supports infrastructure and advanced technology projects, on its PLN 38.3 million investment in Mabion S.A., a biotechnology company in Poland.

Liberty Mutual insurance company, State Street Corporation funds management and Miliken Institute in life sciences are major firms.